T-20 viral fusion inhibitor: Phase II study

By WIR Staff | Dec 21, 1998 | 8:00 AM GMT

Trimeris Inc. (TRMS), Durham, N.C.
Product:

Read the full 62 word article

How to gain access

Continue reading with a
two-week free trial.